tm logo
LEADIANT BIOSCIENCES
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 17 Oct 2022

Last Applicant/ Owned by

21 Holborn Viaduct

London

GB

EC1A2DY

Serial Number

86943755 filed on 17th Mar 2016

Registration Number

5179368 registered on 11th Apr 2017

in the Principal Register

Correspondent Address

Michael N. Mercanti

Michael N. Mercanti

30 BROAD STREET, 21ST FLOOR

NEW YORK, NY 10004

Filing Basis

1. intent to use

Disclaimer

NO DATA

LEADIANT BIOSCIENCES

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of nephrological disorders, inflammatory disorders, cancer and rare diseases, for use in dermatology, in hematology, in oncology, in transplantation, in ophthal Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of nephrological disorders, inflammatory disorders, cancer and rare diseases, for use in dermatology, in hematology, in oncology, in transplantation, in ophthalmology, for use in gastroenterological areas and the prevention and treatment of ocular disorders or diseases; dietary supplements for humans and animals

Mark Details


Serial Number

No 86943755

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 317-21081005

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
17th Oct 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12th Oct 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
14th Apr 2022TEAS SECTION 8 & 15 RECEIVED
11th Apr 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
28th Feb 2018CORRECTION UNDER SECTION 7 ¿ PROCESSED
18th Sep 2017TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
11th Sep 2017POST REGISTRATION ACTION MAILED - SEC. 7
01st Aug 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
17th Jul 2017OTQR WITHDRAWAL FROM PUBLICATION
06th Jul 2017POST REGISTRATION ACTION CORRECTION